Annual CFO
-$23.93 M
+$3.09 M+11.43%
31 December 2023
Summary:
Corvus Pharmaceuticals annual cash flow from operations is currently -$23.93 million, with the most recent change of +$3.09 million (+11.43%) on 31 December 2023. During the last 3 years, it has risen by +$10.84 million (+31.18%). CRVS annual CFO is now -111.29% below its all-time high of -$11.33 million, reached on 31 December 2015.CRVS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$6.32 M
-$840.00 K-15.33%
30 September 2024
Summary:
Corvus Pharmaceuticals quarterly cash flow from operations is currently -$6.32 million, with the most recent change of -$840.00 thousand (-15.33%) on 30 September 2024. Over the past year, it has dropped by -$887.00 thousand (-16.32%). CRVS quarterly CFO is now -268.79% below its all-time high of -$1.71 million, reached on 30 June 2015.CRVS Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$22.13 M
-$887.00 K-4.18%
30 September 2024
Summary:
Corvus Pharmaceuticals TTM cash flow from operations is currently -$22.13 million, with the most recent change of -$887.00 thousand (-4.18%) on 30 September 2024. Over the past year, it has increased by +$4.19 million (+15.92%). CRVS TTM CFO is now -852.07% below its all-time high of -$2.32 million, reached on 31 March 2015.CRVS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRVS Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.4% | -16.3% | +15.9% |
| 3 y3 years | +31.2% | +25.0% | +41.9% |
| 5 y5 years | +41.6% | +40.4% | +40.3% |
CRVS Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +34.8% | -22.6% | +25.0% | -5.5% | +41.9% |
| 5 y | 5 years | at high | +41.6% | -22.6% | +50.0% | -5.5% | +41.9% |
| alltime | all time | -111.3% | +48.2% | -268.8% | +50.4% | -852.1% | +52.1% |
Corvus Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$6.32 M(+15.3%) | -$22.13 M(+4.2%) |
| June 2024 | - | -$5.48 M(+6.3%) | -$21.24 M(+1.2%) |
| Mar 2024 | - | -$5.16 M(-0.2%) | -$20.98 M(-12.3%) |
| Dec 2023 | -$23.93 M(-11.4%) | -$5.17 M(-4.9%) | -$23.93 M(-9.0%) |
| Sept 2023 | - | -$5.43 M(+4.0%) | -$26.32 M(-5.4%) |
| June 2023 | - | -$5.22 M(-35.6%) | -$27.81 M(-3.1%) |
| Mar 2023 | - | -$8.11 M(+7.5%) | -$28.71 M(+6.2%) |
| Dec 2022 | -$27.02 M(-26.4%) | -$7.55 M(+8.9%) | -$27.02 M(+2.6%) |
| Sept 2022 | - | -$6.93 M(+13.2%) | -$26.33 M(-5.4%) |
| June 2022 | - | -$6.12 M(-4.7%) | -$27.83 M(-19.0%) |
| Mar 2022 | - | -$6.42 M(-6.3%) | -$34.35 M(-6.4%) |
| Dec 2021 | -$36.72 M(+5.6%) | -$6.86 M(-18.6%) | -$36.72 M(-3.5%) |
| Sept 2021 | - | -$8.43 M(-33.4%) | -$38.07 M(+1.9%) |
| June 2021 | - | -$12.65 M(+43.9%) | -$37.37 M(+9.2%) |
| Mar 2021 | - | -$8.79 M(+7.1%) | -$34.21 M(-1.6%) |
| Dec 2020 | -$34.78 M(-6.8%) | -$8.21 M(+6.1%) | -$34.78 M(-0.9%) |
| Sept 2020 | - | -$7.73 M(-18.5%) | -$35.08 M(-7.6%) |
| June 2020 | - | -$9.49 M(+1.4%) | -$37.96 M(+0.7%) |
| Mar 2020 | - | -$9.35 M(+9.9%) | -$37.68 M(+1.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$37.32 M(-8.9%) | -$8.51 M(-19.8%) | -$37.32 M(+0.7%) |
| Sept 2019 | - | -$10.61 M(+15.1%) | -$37.07 M(-0.5%) |
| June 2019 | - | -$9.21 M(+2.5%) | -$37.26 M(-4.3%) |
| Mar 2019 | - | -$8.99 M(+8.9%) | -$38.93 M(-5.0%) |
| Dec 2018 | -$40.99 M(-11.3%) | -$8.26 M(-23.5%) | -$40.99 M(-6.2%) |
| Sept 2018 | - | -$10.80 M(-0.8%) | -$43.71 M(+0.1%) |
| June 2018 | - | -$10.89 M(-1.4%) | -$43.69 M(-1.8%) |
| Mar 2018 | - | -$11.04 M(+0.6%) | -$44.51 M(-3.7%) |
| Dec 2017 | -$46.21 M(+65.9%) | -$10.98 M(+1.9%) | -$46.21 M(+3.5%) |
| Sept 2017 | - | -$10.77 M(-8.0%) | -$44.64 M(+10.1%) |
| June 2017 | - | -$11.71 M(-8.1%) | -$40.55 M(+16.0%) |
| Mar 2017 | - | -$12.75 M(+35.5%) | -$34.97 M(+25.5%) |
| Dec 2016 | -$27.86 M(+145.9%) | -$9.41 M(+40.7%) | -$27.86 M(+24.4%) |
| Sept 2016 | - | -$6.68 M(+9.1%) | -$22.39 M(+17.5%) |
| June 2016 | - | -$6.13 M(+8.7%) | -$19.05 M(+30.2%) |
| Mar 2016 | - | -$5.64 M(+43.1%) | -$14.64 M(+29.2%) |
| Dec 2015 | -$11.33 M | -$3.94 M(+17.5%) | -$11.33 M(+53.3%) |
| Sept 2015 | - | -$3.35 M(+95.6%) | -$7.39 M(+83.0%) |
| June 2015 | - | -$1.71 M(-26.2%) | -$4.04 M(+73.8%) |
| Mar 2015 | - | -$2.32 M | -$2.32 M |
FAQ
- What is Corvus Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals annual CFO year-on-year change?
- What is Corvus Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals quarterly CFO year-on-year change?
- What is Corvus Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals TTM CFO year-on-year change?
What is Corvus Pharmaceuticals annual cash flow from operations?
The current annual CFO of CRVS is -$23.93 M
What is the all time high annual CFO for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high annual cash flow from operations is -$11.33 M
What is Corvus Pharmaceuticals annual CFO year-on-year change?
Over the past year, CRVS annual cash flow from operations has changed by +$3.09 M (+11.43%)
What is Corvus Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of CRVS is -$6.32 M
What is the all time high quarterly CFO for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high quarterly cash flow from operations is -$1.71 M
What is Corvus Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, CRVS quarterly cash flow from operations has changed by -$887.00 K (-16.32%)
What is Corvus Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of CRVS is -$22.13 M
What is the all time high TTM CFO for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high TTM cash flow from operations is -$2.32 M
What is Corvus Pharmaceuticals TTM CFO year-on-year change?
Over the past year, CRVS TTM cash flow from operations has changed by +$4.19 M (+15.92%)